T2 Biosystems (NASDAQ:TTOO) reported quarterly losses of $(1.41) per share which beat the analyst consensus estimate of $(1.70) by 17.06 percent. This is a 59.71 percent increase over losses of $(3.50) per share from the same period last year. The company reported quarterly sales of $5.48 million which beat the analyst consensus estimate of $5.40 million by 1.54 percent. This is a 21.45 percent decrease over sales of $6.98 million the same period last year.
T2 Biosystems Q4 EPS $(1.41) Beats $(1.70) Estimate, Sales $5.48M Beat $5.40M Estimate
T2 Biosystems (NASDAQ:TTOO) reported quarterly losses of $(1.41) per share which beat the analyst consensus estimate of $(1.70) by 17.06 percent. This is a 59.71 percent increase over losses of $(3.50) per share from the
